FDA Just Changed the Future of Peptides
Dr. Alex Tatem — FDA Just Changed the Future of Peptides
Channel: Dr. Alex Tatem · Our label: Clinician; paid clinician face of Superpower (disclosed) · Source: youtube.com/watch?v=wP2tPcKjKD8
What this video covers
The FDA just voted to approve four peptides today. We’re talking BPC 157, TB 500, KPV, and MOTS-c, which means the war is over, right? Alex here, board-certified urologist, fellowship-trained in men’s health, specializing in performance medicine, and making solid C-tier videos on the internet. I just rant into a camera, and then it’s up to Veronica to make this into something you can actually tolerate watching.
Summary drawn from this video’s own transcript (banked in our research library, pulled 2026-11-07). Claims below are the speaker’s — attributed, not endorsed. This site publishes no dosing, protocol, or sourcing information.
Key points, in the speaker’s own framing
- The FDA just voted to approve four peptides today.
- We’re talking BPC 157, TB 500, KPV, and MOTS-c, which means the war is over, right?
- Alex here, board-certified urologist, fellowship-trained in men’s health, specializing in performance medicine, and making solid C-tier videos on the internet.
you would be absolutely disgusted with the amount of caffeine and nicotine I have consumed in anticipation of this testimony.
- So, the next step is actually something called a formal rules-based lawmaking where the FDA is going to open up for public comment for 30 to 60 days.
- And I want to encourage every single one of you, if you care about this, if you care about getting safe, legal access to peptides again, make your voices heard.
Read next
- BPC-157 — compound page
- TB-500 — compound page
- MOTS-c — compound page
- Epitalon — compound page
- KPV — compound page
- Dihexa — more videos
- All videos from this channel
Educational information only — not medical advice. Peptides discussed on this page include substances that are not FDA-approved.